Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1791, Issue 4, 2009, Pages 314-320

  Malhotra, Ashim ^a   Xu, Yang ^a   Ren, Mindong ^b   Schlame, Michael ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiolipin; Fatty acid; Mitochondria; Tafazzin

Indexed keywords

CARDIOLIPIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEIN; RECOMBINANT PROTEIN; TAFAZZIN; UNCLASSIFIED DRUG;

ARTICLE; DROSOPHILA; ENZYME SPECIFICITY; ENZYME SUBSTRATE; LIPID ANALYSIS; LIPID METABOLISM; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL;

1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE; ACYLATION; ANIMALS; CARDIOLIPINS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; FATTY ACIDS; MITOCHONDRIA, LIVER; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2; RATS;

HEXAPODA;

EID: 62249151764     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.01.004     Document Type: Article

References (41)

1. Lands W.E. Metabolism of glycerolipids. II. The enzymatic acylation of lysolecithin. J. Biol. Chem. 235 (1960) 2233-2237
2. Yamashita A., Sugiura T., and Waku K. Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J. Biochem. 122 (1997) 1-16
3. 2: structure and function. Biochim. Biophys. Acta 1488 (2000) 28-39
4. Cao J., Liu Y., Lockwood J., Burn P., and Shi Y. A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouse. J. Biol. Chem. 279 (2004) 31727-31734
5. Yang Y., Cao J., and Shi Y. Identification and characterization of a gene encoding human LPGAT1, an endoplasmic reticulum-associated lysophosphatidylglycerol acyltransferase. J. Biol. Chem. 279 (2004) 55866-55874
6. Nakanishi H., Shindou H., Hishikawa D., Harayama T., Ogasawara R., Suwabe A., Taguchi R., and Shimizu T. Cloning and characterization of mouse lung-type acyl-CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1). Expression in alveolar type II cells and possible involvement in surfactant production. J. Biol. Chem. 281 (2006) 20140-20147
7. Chen X., Hyatt B.A., Mucenski M.L., Mason R.J., and Shannon J.M. Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 11724-11729
8. Riekhof W.R., Wu J., Jones J.L., and Voelker D.R. Identification and characterization of the major lysophosphatidylethanolamine acyltransferase in Saccharomyces cerevisiae. J. Biol. Chem. 282 (2007) 28344-28352
9. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J. Lipid Res. 49 (2008) 1607-1620
10. Schlame M., Towbin J.A., Heerdt P.M., Jehle R., DiMauro S., and Blanck T.J.J. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann. Neurol. 51 (2002) 634-637
11. Wang H.J., Jackson S.N., and Woods A.S. Direct MALDI-MS analysis of cardiolipin from rat organs sections. J. Am. Soc. Mass Spectrom. 18 (2007) 567-577
12. Kraffe E., Soudant P., Marty Y., Kervarec N., and Jehan P. Evidence of a tetradocosahexaenoic cardiolipin in some marine bivalves. Lipids 37 (2002) 507-514
13. Schlame M., Ren M., Xu Y., Greenberg M.L., and Haller I. Molecular symmetry in mitochondrial cardiolipins. Chem. Phys. Lipids 138 (2005) 38-49
14. Vreken P., Valianpour F., Nijtmans L.G., Grivell L.A., Plecko B., Wanders R.J.A., and Barth P.G. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem. Biophys. Res. Commun. 279 (2000) 378-382
15. Schlame M., Kelley R.I., Feigenbaum A., Towbin J.a., Heerdt P.M., Schieble T., Wanders R.J.A., DiMauro S., and Blanck T.J.J. Phospholipid abnormalities in children with Barth syndrome. J. Am. Coll. Cardiol. 42 (2003) 1994-1999
16. Gu Z., Valianpour F., Chen S., Vaz F.M., Hakkaart G.A., Wanders R.J.A., and Greenberg M.L. Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome. Mol. Microbiol. 51 (2004) 149-158
17. Schlame M., and Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 580 (2006) 5450-5455
18. Hauff K.D., and Hatch G.M. Cardiolipin metabolism and Barth syndrome. Progr. Lipid Res. 45 (2006) 91-101
19. Li G., Chen S., Thompson M.N., and Greenberg M.L. New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome. Biochim. Biophys. Acta 1771 (2007) 432-441
20. Xu Y., Malhotra A., Ren M., and Schlame M. The enzymatic function of tafazzin. J. Biol. Chem. 281 (2006) 39217-39224
21. Amidon B., Brown A., and Waite M. Transacylase and phospholipases in the synthesis of bis(monoacylglycero)phosphate. Biochemistry 35 (1996) 13995-14002
22. Schmid H.H. Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?. Chem. Phys. Lipids 108 (2000) 71-87
23. 2 family. Progr. Lipid Res. 45 (2006) 487-510
24. Wang A., and Dennis E.A. Mammalian lysophospholipases. Biochim. Biophys. Acta 1439 (1999) 1-16
25. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
26. Schlame M., and Rustow B. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem. J. 272 (1990) 589-595
27. Xu Y., Condell M., Plesken H., Edelman-Novemsky I., Ma J., Ren M., and Schlame M. A Drosophila model of Barth syndrome. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 11584-11588
28. Schlame M., Shanske S., Doty S., Konig T., Sculco T., DiMauro S., and Blanck T.J.J. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. J. Lipid Res. 40 (1999) 1585-1592
29. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
30. Xu Y., Kelley R.I., Blanck T.J.J., and Schlame M. Remodeling of cardiolipin by phospholipid transacylation. J. Biol. Chem. 278 (2003) 51380-51385
31. 2+-independent degradation of mitochondrial phospholipids. Biochemistry 41 (2002) 7771-7780
32. 2) attenuates mitochondrial phospholipid loss and is cardioprotective. Biochem. J. 362 (2002) 23-32
33. 2γ. J. Biol. Chem. 282 (2007) 9216-9227
34. Esposti M.D., Cristea I.M., Gaskell S.J., Nakao Y., and Dive C. Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ. 10 (2003) 1300-1309
35. Tyurin V.A., Tyurina Y.Y., Osipov A.N., Belikova N.A., Basova L.V., Kapralov A.A., Bayir H., and Kagan V.E. Interactions of cardiolipin and lyso-cardiolipins with cytochrome c and tBid: conflict or assistance in apoptosis. Cell Death Differ. 14 (2007) 872-875
36. Valianpour F., Mitsakos V., Schlemmer D., Towbin J.A., Taylor J.M., Ekert P.G., Thorburn D.R., Munnich A., Wanders R.J.A., Barth P.G., and Vaz F.M. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. J. Lipid Res. 46 (2005) 1182-1195
37. 2γ leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype. J. Biol. Chem. 282 (2007) 34611-34622
38. 2 in the pathogenesis of Barth syndrome. Proc. Natl. Acad. Sci. USA (in press), doi:10.1073/pnas.0811224106.
39. Pluckthun A., and Dennis E.A. Acyl and phosphoryl migration in lysophospholipids: importance in phospholipid synthesis and phospholipase specificity. Biochemistry 21 (1982) 1743-1750
40. Creer M.H., and Gross R.W. Separation of isomeric lysophospholipids by reverse phase HPLC. Lipids 20 (1985) 922-928
41. M. Schlame, Formation of molecular species of mitochondrial cardiolipin. 2. A statistical model of pattern formation by phospholipid transacylation, Biochim. Biophys. Acta, submitted for publication.